Role of bone turnover markers in prediction of fracture healing: a contemporary evidence-based perspective
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20261244Keywords:
Bone biomarkers, Bone healing, Fracture, Prognosis, Bone turnoverAbstract
Early and accurate assessment of fracture healing is limited by reliance on plain radiography, which detects only late mineralized changes and fails to capture early biological events, contributing to delayed union and non-union in 5-10% of cases. Bone turnover markers such as PINP, BALP, CTX, and TRACP-5b provide dynamic biochemical insight into osteoblast osteoclast activity and offer potential for earlier prediction of fracture healing outcomes. This review used a structured search of PubMed/MEDLINE, Scopus, Web of Science, and EMBASE up to December 2025 to synthesize mechanistic, diagnostic, and clinical evidence on BTMs in fracture healing. Successful fracture healing shows reproducible temporal BTM patterns, with early rises in CTX and TRACP-5b during days 3-7, followed by a 30-70% increase in PINP and BALP during weeks 2-4. Impaired healing is associated with blunted PINP and BALP responses and/or persistently elevated CTX beyond week 6, with reported odds ratios of 3-5 for delayed or non-union. Clinical application is limited by assay heterogeneity, circadian and metabolic variability, inconsistent sampling protocols, and the lack of fracture-specific cut-off values. An integrated Biochemical Biomechanical Radiological (BBR) Trifecta Model combining BTMs, mechanical stability metrics, and advanced imaging is proposed to improve prognostic accuracy. BTMs offer biologically sensitive and time-dependent information that complements radiography and enable early identification of patients at risk for delayed or impaired fracture healing. Integration through the proposed BBR model, supported by emerging biomarkers and AI-based analytics, may allow precise and personalized fracture monitoring.
Metrics
References
Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015;11(1):45-54. DOI: https://doi.org/10.1038/nrrheum.2014.164
Corrales LA, Morshed S, Bhandari M, Miclau T. Variability in the assessment of fracture-healing in orthopaedic trauma studies. J Bone Joint Surg Am. 2008;90(9):1862-8. DOI: https://doi.org/10.2106/JBJS.G.01580
Mills LA, Aitken SA, Simpson AHRW. The risk of non-union per fracture: current myths and revised figures from a population of over 4 million adults. Acta Orthop. 2017;88(4):434-9. DOI: https://doi.org/10.1080/17453674.2017.1321351
Cox G, Einhorn TA, Tzioupis C, Giannoudis PV. Bone-turnover markers in fracture healing. J Bone Joint Surg Br. 2010;92(3):329-34.
Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391-420.
Janckila AJ, Takahashi K, Sun SZ, Yam LT. Tartrate-resistant acid phosphatase isoform 5b as serum marker for osteoclastic activity. Clin Chem. 2001;47(1):74-80. DOI: https://doi.org/10.1093/clinchem/47.1.74
Bauer D, Krege J, Lane N, Leary E, Libanati C, Miller P, et al. National Bone Health Alliance Bone Turnover Marker Project: current practices and the need for US harmonization, standardization, and common reference ranges. Osteoporos Int. 2012;23(10):2425-33. DOI: https://doi.org/10.1007/s00198-012-2049-z
Phillips AM. Overview of the fracture healing cascade. Injury. 2005;36(3):S5-7. DOI: https://doi.org/10.1016/j.injury.2005.07.027
Gläser N, Schröder M, Barcik J, Haffner-Luntzer M, Wehrle E. Extended view on the mechanobiology of fracture healing: interplay between mechanics and inflammation. Front Bioeng Biotechnol. 2025;13:1652897. DOI: https://doi.org/10.3389/fbioe.2025.1652897
Hu DP, Ferro F, Yang F, Taylor AJ, Chang W, Miclau T, et al. Cartilage to bone transformation during fracture healing is coordinated by the invading vasculature and induction of the core pluripotency genes. Development. 2017;144(2):221-34. DOI: https://doi.org/10.1242/dev.130807
Alexander KA, Chang MK, Maylin ER, Kohler T, Müller R, Wu AC, et al. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model. J Bone Miner Res. 2011;26(7):1517-32. DOI: https://doi.org/10.1002/jbmr.354
Vi L, Baht GS, Whetstone H, Ng A, Wei Q, Poon R, et al. Macrophages promote osteoblastic differentiation in-vivo: implications in fracture repair and bone homeostasis. J Bone Miner Res. 2015;30(6):1090-102. DOI: https://doi.org/10.1002/jbmr.2422
Schmidt-Bleek K, Schell H, Schulz N, Hoff P, Perka C, Buttgereit F, et al. Inflammatory phase of bone healing initiates the regenerative healing cascade. Cell Tissue Res. 2012;347(3):567-73. DOI: https://doi.org/10.1007/s00441-011-1205-7
Einhorn TA. The science of fracture healing. J Orthop Trauma. 2005;19(10):S4-6. DOI: https://doi.org/10.1097/00005131-200511101-00002
Bahney CS, Zondervan RL, Allison P, Theologis A, Ashley JW, Ahn J, et al. Cellular biology of fracture healing. J Orthop Res. 2019;37(1):35-50. DOI: https://doi.org/10.1002/jor.24170
Yang Q, Chen S, Yu Z, Wen X, Ou S. Advances in noninvasive diagnosis of renal osteodystrophy. Ren Fail. 2025;47(1):2593710. DOI: https://doi.org/10.1080/0886022X.2025.2593710
Tang SJ, Meikle MC, MacLaine JK, Wong RW, Rabie BM. Altered serum levels of the osteoclast-specific TRACP 5b isoform in Chinese children undergoing orthodontic treatment. Eur J Orthod. 2013;35(2):169-74. DOI: https://doi.org/10.1093/ejo/cjs013
Cavagis A, Takamori E, Granjeiro J, Oliveira R, Ferreira C, Peppelenbosch M, et al. TNFα contributes to attenuating both Y397FAK and Y416Src phosphorylations in osteoblasts. Oral Dis. 2014;20(8):780-6. DOI: https://doi.org/10.1111/odi.12202
Aggarwal J, Modi M, Gupta RN, Pasha EH. Utility of bone turnover markers in metabolic bone diseases. Santosh Univ J Health Sci. 2023;9(1):48-52. DOI: https://doi.org/10.4103/sujhs.sujhs_38_23
Schini M, Vilaca T, Gossiel F, Salam S, Eastell R. Bone turnover markers: basic biology to clinical applications. Endocr Rev. 2023;44(3):417-73. DOI: https://doi.org/10.1210/endrev/bnac031
Yoon BH, Yu W. Clinical utility of biochemical marker of bone turnover: fracture risk prediction and bone healing. J Bone Metab. 2018;25(2):73-8. DOI: https://doi.org/10.11005/jbm.2018.25.2.73
Koivula MK, Risteli L, Risteli J. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum. Clin Biochem. 2012;45(12):920-7. DOI: https://doi.org/10.1016/j.clinbiochem.2012.03.023
Gillett MJ, Vasikaran SD, Inderjeeth CA. The role of PINP in diagnosis and management of metabolic bone disease. Clin Biochem Rev. 2021;42(1):3-10. DOI: https://doi.org/10.33176/AACB-20-0001
Vimalraj S. Alkaline phosphatase: structure, expression and its function in bone mineralization. Gene. 2020;754:144855. DOI: https://doi.org/10.1016/j.gene.2020.144855
Rathwa HS, Verma T, Chavali VH. Assessment of union in fractures: role of serum alkaline phosphatase and ultrasonography. J Clin Orthop Trauma. 2020;14:94-100. DOI: https://doi.org/10.1016/j.jcot.2020.08.004
Tsao YT, Huang YJ, Wu HH, Liu YA, Liu YS, Lee OK. Osteocalcin mediates biomineralization during osteogenic maturation in human mesenchymal stromal cells. Int J Mol Sci. 2017;18(1):159. DOI: https://doi.org/10.3390/ijms18010159
Nowicki JK, Jakubowska-Pietkiewicz E. Osteocalcin: beyond bones. Endocrinol Metab (Seoul). 2024;39(3):399-406. DOI: https://doi.org/10.3803/EnM.2023.1895
Di Medio L, Brandi ML. Advances in bone turnover markers. Adv Clin Chem. 2021;105:101-40. DOI: https://doi.org/10.1016/bs.acc.2021.06.001
Stewart CC, O'Hara NN, Bzovsky S, Bahney CS, Sprague S, Slobogean GP, et al. Bone turnover markers as surrogates of fracture healing after intramedullary fixation of tibia and femur fractures. Bone Joint Res. 2022;11(4):239-50. DOI: https://doi.org/10.1302/2046-3758.114.BJR-2021-0226.R1
Baxter I, Rogers A, Eastell R, Peel N. Evaluation of urinary N-telopeptide of type I collagen measurements in the management of osteoporosis in clinical practice. Osteoporos Int. 2013;24(3):941-7. DOI: https://doi.org/10.1007/s00198-012-2097-4
Lv Y, Wang G, Xu W, Tao P, Lv X, Wang Y. Tartrate-resistant acid phosphatase 5b is a marker of osteoclast number and volume in RAW 264.7 cells treated with receptor-activated nuclear κB ligand. Exp Ther Med. 2015;9(1):143-6. DOI: https://doi.org/10.3892/etm.2014.2071
Wilson SR, Peters C, Saftig P, Brömme D. Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption. J Biol Chem. 2009;284(4):2584-92. DOI: https://doi.org/10.1074/jbc.M805280200
Moghaddam A, Müller U, Roth HJ, Wentzensen A, Grützner PA, Zimmermann G. TRACP 5b and CTX as osteological markers of delayed fracture healing. Injury. 2011;42(8):758-64. DOI: https://doi.org/10.1016/j.injury.2010.11.017
Wang Y, Hu H, Huang Y. Advances in the application of bone turnover markers for pediatric growth and developmental disorders: a review. Front Endocrinol (Lausanne). 2025;16:1615712. DOI: https://doi.org/10.3389/fendo.2025.1615712
Cox G, Einhorn TA, Tzioupis C, Giannoudis PV. Bone-turnover markers in fracture healing. J Bone Joint Surg Br. 2010;92(3):329-34. DOI: https://doi.org/10.1302/0301-620X.92B3.22787
Kushchayeva Y, Pestun I, Kushchayev S, Radzikhovska N, Lewiecki EM. Advancement in the treatment of osteoporosis and the effects on bone healing. J Clin Med. 2022;11(24):7477. DOI: https://doi.org/10.3390/jcm11247477
Farahmand P, Marin F, Hawkins F, Möricke R, Ringe JD, Glüer CC, et al. Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis. Osteoporos Int. 2013;24(12):2971-81. DOI: https://doi.org/10.1007/s00198-013-2379-5
Kotsifaki A, Kalouda G, Maroulaki S, Foukas A, Armakolas A. The genetic and biological basis of pseudoarthrosis in fractures: current understanding and future directions. Diseases. 2025;13(3):75. DOI: https://doi.org/10.3390/diseases13030075
Perut F, Roncuzzi L, Gómez-Barrena E, Baldini N. Association between bone turnover markers and fracture healing in long bone non-union: a systematic review. J Clin Med. 2024;13(8):2333. DOI: https://doi.org/10.3390/jcm13082333
Haarhaus M, Evenepoel P. European Renal Osteodystrophy (EUROD) workgroup; Chronic Kidney Disease Mineral and Bone Disorder (CKD-MBD) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA). Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment. Kidney Int. 2021;100(3):546-58. DOI: https://doi.org/10.1016/j.kint.2021.04.043
Bhattoa HP, Vasikaran S, Trifonidi I, Kapoula G, Lombardi G, Jørgensen NR, et al. Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from the ESCEO, IOF, and IFCC. Osteoporos Int. 2025;36(4):579-608. DOI: https://doi.org/10.1007/s00198-025-07422-3
DK, Betancourt VVV, Madhukar S, Huda M, Cerdas MG, Sunil A, et al. Radiological innovations for monitoring bone regeneration and fracture healing. Cureus. 2025;17(11):e97659. DOI: https://doi.org/10.7759/cureus.97659
Aronson JK. Biomarkers and surrogate endpoints. Br J Clin Pharmacol. 2005;59(5):491-4. DOI: https://doi.org/10.1111/j.1365-2125.2005.02435.x
Kim T, Kim H. Pathophysiology and therapeutic management of bone loss in patients with critical illness. Pharmaceuticals (Basel). 2023;16(12):1718. DOI: https://doi.org/10.3390/ph16121718
Shetty S, Kapoor N, Bondu JD, Thomas N, Paul TV. Bone turnover markers: emerging tool in the management of osteoporosis. Indian J Endocrinol Metab. 2016;20(6):846-52. DOI: https://doi.org/10.4103/2230-8210.192914
Jia Z, Tang M, Zhang X, Jiang W, Shen J, Zhou N, et al. Changes in bone turnover markers after osteoporotic vertebral compression fractures in males and females. Biomed Res Int. 2022;2022:5381601. DOI: https://doi.org/10.1155/2022/5381601
Beeharry MW, Ahmad B. Principles of fracture healing and fixation: a literature review. Cureus. 2024;16(12):e76250. DOI: https://doi.org/10.7759/cureus.76250
Lorentzon M, Branco J, Brandi ML, Bruyère O, Chapurlat R, Cooper C, et al. Algorithm for the use of biochemical markers of bone turnover in the diagnosis, assessment and follow-up of treatment for osteoporosis. Adv Ther. 2019;36(10):2811-24. DOI: https://doi.org/10.1007/s12325-019-01063-9
Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. Osteoporos Int. 2011;22(2):391-420. DOI: https://doi.org/10.1007/s00198-010-1501-1
Zhao Q, Zhang C, Zhang W, Zhang S, Liu Q, Guo Y. Applications and challenges of biomarker-based predictive models in proactive health management. Front Public Health. 2025;13:1633487. DOI: https://doi.org/10.3389/fpubh.2025.1633487
Lee C, Copp J. Future modalities to assess fracture healing. OTA Int. 2022;5(1):e161. DOI: https://doi.org/10.1097/OI9.0000000000000161
Baker CE, Moore-Lotridge SN, Hysong AA, Posey SL, Robinette JP, Blum DM, et al. Bone fracture acute phase response-a unifying theory of fracture repair: clinical and scientific implications. Clin Rev Bone Miner Metab. 2018;16(4):142-58. DOI: https://doi.org/10.1007/s12018-018-9256-x
Mermerci Başkan B, Yurdakul FG, Aydın E, Sivas F, Bodur H. Effect of vitamin D levels on radiographic knee osteoarthritis and functional status. Turk J Phys Med Rehabil. 2017;64(1):1-7. DOI: https://doi.org/10.5606/tftrd.2018.986
Betts DC, Müller R. Mechanical regulation of bone regeneration: theories, models, and experiments. Front Endocrinol (Lausanne). 2014;5:211. DOI: https://doi.org/10.3389/fendo.2014.00211
Xu W, Chen YW, Nagatomo K, Liu Y, Zhou J, Dard M, et al. Development of an angular stiffness sensor to measure dental implant stability in vitro. Sensors (Basel). 2024;24(21):6959. DOI: https://doi.org/10.3390/s24216959
Bowers KM, Anderson DE. Delayed union and nonunion: current concepts, prevention, and correction: a review. Bioengineering (Basel). 2024;11(6):525. DOI: https://doi.org/10.3390/bioengineering11060525
Han W, Kang X, He W, Jiang L, Li H, Xu B. A new method for disease diagnosis based on hierarchical BRB with power set. Heliyon. 2023;9(2):e13619. DOI: https://doi.org/10.1016/j.heliyon.2023.e13619
Groven RVM, Van Koll J, Poeze M, Blokhuis TJ, Van Griensven M. miRNAs related to different processes of fracture healing: an integrative overview. Front Surg. 2021;8:786564. DOI: https://doi.org/10.3389/fsurg.2021.786564
Genovese F, Karsdal MA. Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers. Expert Rev Proteomics. 2016;13(2):213-25. DOI: https://doi.org/10.1586/14789450.2016.1134327
Roszkowski S. Therapeutic potential of mesenchymal stem cell-derived exosomes for regenerative medicine applications. Clin Exp Med. 2024;24(1):46-57. DOI: https://doi.org/10.1007/s10238-023-01282-z
Kong SH. Incorporating artificial intelligence into fracture risk assessment: using clinical imaging to predict the unpredictable. Endocrinol Metab (Seoul). 2025;40(4):499-507. DOI: https://doi.org/10.3803/EnM.2025.2518
Seibel MJ. Biochemical markers of bone turnover: part I: biochemistry and variability. Clin Biochem Rev. 2005;26(4):97-122.
Kumar R, Sporn K, Borole A, Khanna A, Gowda C, Paladugu P, et al. Biomarker-guided imaging and AI-augmented diagnosis of degenerative joint disease. Diagnostics (Basel). 2025;15(11):1418. DOI: https://doi.org/10.3390/diagnostics15111418
Murshed M, Harmey D, Millán JL, McKee MD, Karsenty G. Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev. 2005;19(9):1093-104. DOI: https://doi.org/10.1101/gad.1276205
Wu S, Wang L, Zhang X, Cai L, Ke Q, Xu J. Bone turnover markers (β-CTX, PINP, ALP) in osteoporosis: correlation with bone loss and fracture risk stratification. Front Endocrinol (Lausanne). 2026;16:1628434. DOI: https://doi.org/10.3389/fendo.2025.1628434
Højsager FD, Rand MS, Pedersen SB, Nissen N, Jørgensen NR. Fracture-induced changes in biomarkers CTX, PINP, OC, and BAP-a systematic review. Osteoporos Int. 2019;30(12):2381-9. DOI: https://doi.org/10.1007/s00198-019-05132-1
Downloads
Published
How to Cite
Issue
Section
